{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:36:44Z","timestamp":1768275404201,"version":"3.49.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/or.2015.4145","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T10:37:00Z","timestamp":1437647820000},"page":"2065-2071","source":"Crossref","is-referenced-by-count":20,"title":["Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells"],"prefix":"10.3892","volume":"34","author":[{"given":"SANG HYUK","family":"LEE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HYO JUNG","family":"NAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HYUN JUNG","family":"KANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TINA L.","family":"SAMUELS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIKKI","family":"JOHNSTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUNG CHANG","family":"LIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"key20180107212015_b1-or-34-04-2065","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107212015_b2-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180107212015_b3-or-34-04-2065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"key20180107212015_b4-or-34-04-2065","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212015_b5-or-34-04-2065","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107212015_b6-or-34-04-2065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212015_b7-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","article-title":"Cancer stem cells","volume":"355","author":"Jordan","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107212015_b8-or-34-04-2065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2010.11.011","article-title":"Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas","volume":"47","author":"Lim","year":"2011","journal-title":"Oral Oncol"},{"key":"key20180107212015_b9-or-34-04-2065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejca.2012.06.004","article-title":"CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits","volume":"49","author":"Oh","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180107212015_b10-or-34-04-2065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.cr.7310118","article-title":"Beyond tumorigenesis: Cancer stem cells in metastasis","volume":"17","author":"Li","year":"2007","journal-title":"Cell Res"},{"key":"key20180107212015_b11-or-34-04-2065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107212015_b12-or-34-04-2065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"key20180107212015_b13-or-34-04-2065","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.ejca.2012.04.013","article-title":"All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt\/\u03b2-catenin pathway","volume":"48","author":"Lim","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20180107212015_b14-or-34-04-2065","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.ejca.2013.06.025","article-title":"Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway","volume":"49","author":"Lee","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180107212015_b15-or-34-04-2065","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1073\/pnas.0910179107","article-title":"Selective targeting of radiation-resistant tumor-initiating cells","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212015_b16-or-34-04-2065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20180107212015_b17-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol"},{"key":"key20180107212015_b18-or-34-04-2065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: Implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"key20180107212015_b19-or-34-04-2065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: Causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"key20180107212015_b20-or-34-04-2065","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107212015_b21-or-34-04-2065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","article-title":"Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis","volume":"5","author":"Zhu","year":"2004","journal-title":"Cancer Cell"},{"key":"key20180107212015_b22-or-34-04-2065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ng1773","article-title":"A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition","volume":"38","author":"Ropero","year":"2006","journal-title":"Nat Genet"},{"key":"key20180107212015_b23-or-34-04-2065","doi-asserted-by":"crossref","first-page":"e58672","DOI":"10.1371\/journal.pone.0058672","article-title":"Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer","volume":"8","author":"Giudice","year":"2013","journal-title":"PLoS One"},{"key":"key20180107212015_b24-or-34-04-2065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"key20180107212015_b25-or-34-04-2065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: Past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107212015_b26-or-34-04-2065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","article-title":"Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy","volume":"269","author":"Carew","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180107212015_b27-or-34-04-2065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107212015_b28-or-34-04-2065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00280-008-0747-1","article-title":"Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas","volume":"63","author":"Erlich","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107212015_b29-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-06-2569","article-title":"The identification of (ETV6)\/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6\/RUNX1-positive lymphoid leukemic cells","volume":"13","author":"Starkova","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107212015_b30-or-34-04-2065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/00001813-199711000-00007","article-title":"Sodium valproate inhibits in vivo growth of human neuroblastoma cells","volume":"8","author":"Cinatl","year":"1997","journal-title":"Anticancer Drugs"},{"key":"key20180107212015_b31-or-34-04-2065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies","volume":"25","author":"Blaheta","year":"2005","journal-title":"Med Res Rev"},{"key":"key20180107212015_b32-or-34-04-2065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2011.12.041","article-title":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","volume":"319","author":"Zapotocky","year":"2012","journal-title":"Cancer Lett"},{"key":"key20180107212015_b33-or-34-04-2065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","article-title":"Valproic acid in the complex therapy of malignant tumors","volume":"11","author":"Hrebackova","year":"2010","journal-title":"Curr Drug Targets"},{"key":"key20180107212015_b34-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/carcin\/bgt019","article-title":"Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2","volume":"34","author":"Witt","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180107212015_b35-or-34-04-2065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hed.21734","article-title":"Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence","volume":"34","author":"Gan","year":"2012","journal-title":"Head Neck"},{"key":"key20180107212015_b36-or-34-04-2065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4149\/neo_2012_093","article-title":"Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors","volume":"59","author":"Khalil","year":"2012","journal-title":"Neoplasma"},{"key":"key20180107212015_b37-or-34-04-2065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2184.2009.00633.x","article-title":"Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells","volume":"42","author":"Lee","year":"2009","journal-title":"Cell Prolif"},{"key":"key20180107212015_b38-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107212015_b39-or-34-04-2065","doi-asserted-by":"crossref","first-page":"e18087","DOI":"10.1371\/journal.pone.0018087","article-title":"HDAC inhibition decreases the expression of EGFR in colorectal cancer cells","volume":"6","author":"Chou","year":"2011","journal-title":"PLoS One"},{"key":"key20180107212015_b40-or-34-04-2065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4149\/neo_2011_03_239","article-title":"Wnt\/\u03b2-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells","volume":"58","author":"Wang","year":"2011","journal-title":"Neoplasma"},{"key":"key20180107212015_b41-or-34-04-2065","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"key20180107212015_b42-or-34-04-2065","first-page":"5195","article-title":"E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas","volume":"55","author":"Graff","year":"1995","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4145\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:20:37Z","timestamp":1515360037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,23]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/or.2015.4145"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4145","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}